Teva Pharmaceutical Industries (NYSE: TEVA) hasn’t had much good news lately. Shares of the Israel-based drugmaker were hit hard in the second half of 2016.
However, the company had a chance to report good news with the announcement of its fourth-quarter and full-year 2016 financial results. Here are the highlights from Teva’s update.
Image source: Getty Images.